CCG
BSX icon

Catalina Capital Group’s Boston Scientific BSX Stock Holding History

Catalina Capital Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-6,140
Closed -$548K – 213
2024
Q4 		$548K Buy
6,140
+236
+4% +$20.8K 0.18% 113
2024
Q3 		$495K Buy
5,904
+326
+6% +$25.7K 0.17% 125
2024
Q2 		$430K Buy
5,578
+169
+3% +$12.4K 0.16% 137
2024
Q1 		$370K Buy
+5,409
New +$348K 0.15% 146

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Catalina Capital Group's BSX Position: Q1 2025 in Review

Catalina Capital Group sold out of Boston Scientific (BSX) in Q1 2025, closing a stake of 6,140 shares — an estimated $548K sold.

Catalina Capital Group first reported a position in BSX in Q1 2024 and held it in 4 quarters. The position peaked at $548K in Q4 2024. 1,642 funds tracked by Wall St. Rank hold BSX as of Q1 2025.

  • Catalina Capital Group reported no remaining Boston Scientific position as of Q1 2025 after selling out during the quarter.
  • Catalina Capital Group sold 6,140 Boston Scientific shares in Q1 2025, an estimated $548K.
  • Catalina Capital Group first reported a position in Boston Scientific in Q1 2024 and held it in 4 quarters.
  • Catalina Capital Group's Boston Scientific position peaked at $548K in Q4 2024.
  • 1,642 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2025.

Based on Catalina Capital Group's 13F filing for Q1 2025, filed 21 Apr 2025.